This project addresses the biotechnology and pharmaceutical industries’ need for mature, physiologically relevant cardiac models for drug discovery, cardiotoxicity testing, and personalized medicine. Existing models, such as human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs), lack the structural and functional maturity needed for reliable applications. The UBC MEMS Lab has developed a soft, micropatterned substrate and a […]
Read More